Petros Pharm Inc (PTPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -987 | 1,914 | 2,250 | 3,173 | -2,260 |
| Accounts payable and accrued liabilities | 49 | -681 | -343 | 206 | -212 |
| Other Working Capital | 82 | -664 | 7 | 292 | -164 |
| Other Operating Activity | 71 | -7,304 | -7,715 | -8,338 | 976 |
| Operating Cash Flow | $-784 | $-6,735 | $-5,801 | $-4,667 | $-1,660 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 8,503 | 8,503 | 8,503 | 8,707 |
| Other Financing Activity | 0 | -342 | -342 | -224 | 0 |
| Financing Cash Flow | $N/A | $8,162 | $8,162 | $8,279 | $8,707 |
| Beginning Cash Position | 5,137 | 3,710 | 3,710 | 3,710 | 3,710 |
| End Cash Position | 4,353 | 5,137 | 6,070 | 7,322 | 10,757 |
| Net Cash Flow | $-784 | $1,427 | $2,360 | $3,612 | $7,047 |
| Free Cash Flow | |||||
| Operating Cash Flow | -784 | -6,735 | -5,801 | -4,667 | -1,660 |
| Free Cash Flow | -784 | -6,735 | -5,801 | -4,667 | -1,660 |